Aspen Pharmacare expects African sales of Eli Lilly's blockbuster weight-loss and diabetes drug Mounjaro to exceed 2 ‌billion rand ($124 million) in its current financial year, buoyed by surging ...

The FDA has approved Mounjaro to reduce cardiovascular risk in people with type 2 diabetes after a major trial found it ...

For decades, type 2 diabetes was managed with medicines that either pushed insulin higher or improved how the body used it. GLP-1 medicines have changed that pattern. They only stimulate insulin when ...